Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03508271 · ClinicalTrials.gov registry record
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
A clinical trial of Heart Failure and Atrial Fibrillation, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 60,000
- Enrollment target
- 1
- Study location
NCT03508271 is a study of Heart Failure and Atrial Fibrillation that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 60,000 participants, above the 1,898-participant average among 397 other Heart Failure trials with a reported enrollment target (3061% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03508271, a study of Heart Failure and Atrial Fibrillation, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 60,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
Conditions Studied
Interventions
- OTHER Non-Interventional
Study Locations (1)
Michigan
- Local Institution - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2018-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03508271
The ClinicalTrials.gov registry entry for NCT03508271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,898-participant average among 397 other Heart Failure trials with a reported enrollment target (3061% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional is the first listed.
NCT03508271 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03508271 about?
NCT03508271 is a clinical study titled "Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure". Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
What is the current status of trial NCT03508271?
This trial is currently completed. The enrollment target is 60,000 participants. The study started on 2017-11-30. Estimated completion is 2018-11-08.
What conditions does trial NCT03508271 study?
This clinical trial studies the following conditions: Heart Failure, Atrial Fibrillation.
What interventions are being tested in trial NCT03508271?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT03508271?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03508271 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.